Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diarrhea | 6 | 2024 | 23 | 1.720 |
Why?
|
| Drugs, Chinese Herbal | 4 | 2023 | 12 | 1.390 |
Why?
|
| Intestines | 5 | 2023 | 15 | 0.960 |
Why?
|
| Biliary Tract | 2 | 2020 | 5 | 0.750 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2021 | 66 | 0.710 |
Why?
|
| Glucuronosyltransferase | 3 | 2021 | 30 | 0.710 |
Why?
|
| Intestinal Mucosa | 4 | 2024 | 26 | 0.700 |
Why?
|
| Animals | 17 | 2024 | 1711 | 0.650 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2020 | 44 | 0.650 |
Why?
|
| Rats, Inbred F344 | 5 | 2024 | 21 | 0.550 |
Why?
|
| Mice | 9 | 2024 | 685 | 0.480 |
Why?
|
| Tissue Distribution | 5 | 2024 | 26 | 0.450 |
Why?
|
| Rats | 8 | 2024 | 241 | 0.400 |
Why?
|
| Glucuronidase | 2 | 2023 | 7 | 0.390 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 19 | 0.380 |
Why?
|
| Multidrug Resistance-Associated Proteins | 2 | 2023 | 8 | 0.350 |
Why?
|
| Raloxifene Hydrochloride | 2 | 2021 | 5 | 0.340 |
Why?
|
| Male | 10 | 2024 | 2491 | 0.330 |
Why?
|
| Chromatography, Liquid | 2 | 2021 | 37 | 0.280 |
Why?
|
| Flavonoids | 3 | 2019 | 20 | 0.260 |
Why?
|
| Glucuronides | 4 | 2021 | 28 | 0.230 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2024 | 9 | 0.220 |
Why?
|
| Camptothecin | 1 | 2024 | 9 | 0.220 |
Why?
|
| Feces | 1 | 2024 | 26 | 0.210 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 225 | 0.210 |
Why?
|
| Rats, Wistar | 3 | 2019 | 31 | 0.200 |
Why?
|
| Bile | 2 | 2020 | 7 | 0.200 |
Why?
|
| Osteoarthritis | 1 | 2023 | 4 | 0.200 |
Why?
|
| Area Under Curve | 2 | 2020 | 16 | 0.200 |
Why?
|
| Caco-2 Cells | 2 | 2020 | 21 | 0.200 |
Why?
|
| Gastrointestinal Diseases | 1 | 2023 | 4 | 0.190 |
Why?
|
| Plants, Medicinal | 1 | 2023 | 5 | 0.190 |
Why?
|
| Female | 5 | 2024 | 2523 | 0.190 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 69 | 0.180 |
Why?
|
| Fenoldopam | 1 | 2021 | 2 | 0.180 |
Why?
|
| Humans | 7 | 2024 | 4936 | 0.170 |
Why?
|
| Bupleurum | 1 | 2021 | 1 | 0.170 |
Why?
|
| Lignans | 1 | 2021 | 5 | 0.170 |
Why?
|
| Esterases | 1 | 2020 | 5 | 0.160 |
Why?
|
| Hepatobiliary Elimination | 2 | 2019 | 5 | 0.160 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2019 | 7 | 0.150 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 160 | 0.150 |
Why?
|
| Umbelliferones | 1 | 2019 | 3 | 0.150 |
Why?
|
| Membrane Transport Proteins | 1 | 2018 | 12 | 0.150 |
Why?
|
| Polyphenols | 1 | 2018 | 8 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 17 | 0.140 |
Why?
|
| Models, Biological | 1 | 2018 | 124 | 0.130 |
Why?
|
| Liver | 4 | 2021 | 49 | 0.130 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 3 | 0.120 |
Why?
|
| Diterpenes | 1 | 2015 | 3 | 0.120 |
Why?
|
| Lactones | 1 | 2015 | 10 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 126 | 0.110 |
Why?
|
| Biological Availability | 3 | 2021 | 14 | 0.110 |
Why?
|
| Intestinal Absorption | 3 | 2019 | 9 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 318 | 0.090 |
Why?
|
| Molecular Structure | 2 | 2021 | 84 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 125 | 0.080 |
Why?
|
| Sulfates | 2 | 2021 | 6 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 184 | 0.080 |
Why?
|
| Gastrointestinal Tract | 2 | 2022 | 4 | 0.070 |
Why?
|
| Limit of Detection | 2 | 2021 | 27 | 0.070 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2024 | 14 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 52 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 51 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 17 | 0.050 |
Why?
|
| Injections, Intra-Articular | 1 | 2023 | 2 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 5 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 10 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2023 | 9 | 0.050 |
Why?
|
| Cytokines | 1 | 2023 | 37 | 0.050 |
Why?
|
| Phytotherapy | 1 | 2023 | 5 | 0.050 |
Why?
|
| Inflammation | 1 | 2023 | 57 | 0.050 |
Why?
|
| Pain | 1 | 2023 | 41 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 87 | 0.040 |
Why?
|
| Glucuronates | 1 | 2021 | 2 | 0.040 |
Why?
|
| Piperidines | 1 | 2021 | 15 | 0.040 |
Why?
|
| Linear Models | 1 | 2021 | 58 | 0.040 |
Why?
|
| Age Factors | 1 | 2021 | 65 | 0.040 |
Why?
|
| Antioxidants | 1 | 2021 | 23 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2021 | 15 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 20 | 0.040 |
Why?
|
| Fatty Alcohols | 1 | 2019 | 2 | 0.040 |
Why?
|
| Saponins | 1 | 2019 | 3 | 0.040 |
Why?
|
| Catechols | 1 | 2019 | 3 | 0.040 |
Why?
|
| Diketopiperazines | 1 | 2019 | 2 | 0.040 |
Why?
|
| Propionates | 1 | 2019 | 3 | 0.040 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2019 | 3 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 2019 | 5 | 0.040 |
Why?
|
| Perfusion | 1 | 2019 | 9 | 0.040 |
Why?
|
| Enzymes | 1 | 2018 | 4 | 0.040 |
Why?
|
| Quinolines | 1 | 2019 | 21 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2019 | 140 | 0.030 |
Why?
|
| Microsomes | 1 | 2016 | 5 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 2016 | 15 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2014 | 8 | 0.030 |
Why?
|